Central Retinal Vein Occlusion (CRVO)
What Is Central Retinal Vein Occlusion?
CRVO develops when a blood clot or narrowing within the central retinal vein slows or stops the normal outflow of blood from the retina.
The blockage prevents blood from leaving the eye, leading to swelling, bleeding, and reduced oxygen delivery to retinal tissue.
Fluid leaks into the macula, the area responsible for sharp central vision, causing images to look distorted or out of focus.
Types of CRVO
CRVO is grouped into two main categories that differ in severity and outlook.
This milder form accounts for about seventy percent of cases. Vision may be better than 20/200, and some patients recover fully with careful monitoring.
- Leakage from retinal vessels causes mild blurring that can fluctuate.
- Regular follow-up is needed because some cases convert to the ischemic type.
Ischemic CRVO involves severe blockage and oxygen deprivation.
- Vision is often worse than 20/200 with extensive hemorrhages and cotton-wool spots.
- Complications such as neovascular glaucoma can develop without prompt care.
Symptoms and Vision Changes
Symptoms vary based on the degree of blockage and swelling but usually appear in one eye.
The most common sign is gradual or sudden blurring that may involve the entire visual field or just the center.
Some patients notice an abrupt drop in sight that can progress to severe loss if untreated.
Dark spots or squiggles may drift across vision as leaked blood cells cast shadows inside the eye.
In advanced cases the eye can feel pressured or appear red, especially if new abnormal vessels begin to form.
Risk Factors and Causes
Understanding what leads to CRVO helps guide prevention and treatment.
Certain medical issues damage blood vessels and raise CRVO risk.
- High blood pressure
- Diabetes
- High cholesterol
- Blood clotting disorders and autoimmune diseases
Problems within the eye itself can trigger vein blockage.
- Open-angle glaucoma with elevated eye pressure
- Previous eye trauma or surgery
Choices and rare illnesses also play a role.
- Smoking and obesity
- Hyperviscosity syndromes such as multiple myeloma
- Inflammatory or infectious diseases in younger patients
Diagnosis and Evaluation
A thorough eye exam pinpoints the type and severity of CRVO.
After pupil-dilating drops, the retina is inspected for bleeding, swelling, and vessel changes.
OCT captures detailed cross-section images of retinal layers to measure macular edema and track treatment response.
A dye highlights retinal circulation, revealing blocked or leaking vessels and areas lacking oxygen.
Visual acuity and field tests help distinguish non-ischemic from ischemic CRVO and monitor progress over time.
Treatment Options
The goal of therapy is to reduce swelling, prevent complications, and preserve vision.
Medications such as bevacizumab, ranibizumab, or aflibercept lower vascular endothelial growth factor levels, decreasing leakage and macular edema.
Intravitreal steroids reduce inflammation when anti-VEGF therapy alone is insufficient, but they require careful pressure monitoring.
Panretinal photocoagulation treats areas with poor blood flow to lower the stimulus for harmful new vessel growth.
In select cases tissue plasminogen activator injections or vitrectomy surgery may be considered.
Possible Complications
Untreated CRVO can cause additional eye problems that threaten sight.
Persistent swelling in the macula can result in long-term blurring and vision distortion.
Fragile new vessels grow on the iris and drainage angle, raising eye pressure and creating pain and further vision loss.
Statistics You Should Know
Research highlights the importance of regular monitoring and timely care.
More than ninety percent of ischemic CRVO cases lead to severe vision impairment below 20/200, while only about ten percent of non-ischemic cases regain full vision.
Up to one third of non-ischemic CRVO cases progress to the ischemic form within three years, stressing the need for follow-up visits.
Frequently Asked Questions
Below are common questions patients ask during their CRVO visit.
Your eye exam and imaging tests reveal whether the blockage is non-ischemic or ischemic, which guides treatment and prognosis.
Most patients are seen every four to eight weeks at first, then less often as the condition stabilizes.
Your retina specialist will review the expected vision gains and possible side effects of injections, laser, or other therapies.
Repeat OCT or angiography may be scheduled to track swelling, blood flow, and response to treatment.
Controlling blood pressure, blood sugar, and cholesterol, along with quitting smoking and staying active, lowers the chance of further vessel problems.
Protecting Your Sight
Prompt evaluation and ongoing care are the best defenses against vision loss from CRVO. Our team is dedicated to guiding you through diagnosis, treatment, and long-term monitoring so that you can maintain the clearest vision possible.
I take my mother here monthly the staff is amazing, always welcoming and attentive. Keep up the wonderful job.
Scully Sully
El Dr. Fernández y su equipo son profesionales, atentos y siempre están pendientes de los pacientes. Tratan a cada paciente como a una persona digna de atención personal y dedicación completa.
SS
ClÃnica fantástica. El Dr. Fernández resuelve rápidamente los problemas que ve en el momento y recomienda soluciones para seguir adelante. Siempre hay disponibilidad para emergencias, etc.
Shyam Srinivasan
Siempre es un placer ver al Dr. Fernandes. El doctor y el personal son muy profesionales, amables y comprensivos.
Christina
This place is great the doctor really takes his time with patients. He explains treatments and procedures well, staff are friendly, and they even offer a breakfast bar for everyone.
SLK Production